Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings

Francesco D’Oria; Francesco Piscazzi; Paola Facheris; Giulio Foggi; Marco Ardigò; Antonio Costanzo; Mario Valenti

doi:10.1007/s13555-026-01742-w

April 9, 2026Dermatology and TherapyOpen Access

Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to evaluate the effectiveness of deucravacitinib in treating refractory discoid lupus and concomitant psoriasis.
Observed the effects of deucravacitinib on patients with refractory discoid lupus and psoriasis.
Utilized confocal microscopy to support findings.
Monitored clinical outcomes and remission rates during treatment.
Deucravacitinib showed significant improvement in discoid lupus symptoms.
Patients experienced remission of psoriasis alongside lupus treatment.
Confocal microscopy findings supported the therapeutic effects observed.

Implication

A case highlights deucravacitinib's effectiveness in treating discoid lupus and psoriasis, suggesting its potential value in autoimmunity.

Abstract

This case highlights the potential of deucravacitinib as an effective therapeutic option for refractory DLE, particularly in patients with concomitant psoriasis, supporting TYK2 inhibition as a promising targeted strategy in cutaneous autoimmunity.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

D’Oria et al. (2026) studied this question.

synapsesocial.com/papers/69db365c4fe01fead37c47cb https://doi.org/10.1007/s13555-026-01742-w

View Full Paper

Ask AI

Bookmark

Share

Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings

Key Points

Implication

Abstract

Discussion

Cite This Study

Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading